Showing results (341-350 of 561) with videos related to
Sort By:
Pageof 57
The Lancet. Oncology|September 14, 2013
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trialDavid Cunningham, Istvan Lang, Eugenio Marcuello, et al.JAMA Oncology|May 26, 2018
Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric CancerSheraz R Markar, Tom Wiggins, Stefan Antonowicz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331Hugo E R Ford, Fraser Mitchell, David Cunningham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junctionAndrew R Davies, James A Gossage, Janine Zylstra, et al.Journal of Pathology Informatics|February 23, 2023
Automated detection and delineation of lymph nodes in haematoxylin & eosin stained digitised slidesManon Beuque, Derek R Magee, Avishek Chatterjee, et al.NPJ Precision Oncology|January 13, 2026
Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trialTing Pu, Allyson M Peddle, Pratyaksha Wirapati, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2021
Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)Manish A Shah, Gyorgy Bodoky, Alexander Starodub, et al.Blood|October 21, 2004
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphomaRobert Marcus, Kevin Imrie, Andrew Belch, et al.The New England Journal of Medicine|July 23, 2004
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancerDavid Cunningham, Yves Humblet, Salvatore Siena, et al.BMJ Health & Care Informatics|September 22, 2025
Supporting cancer research on real-world data: extracting colorectal cancer status and explicitly written TNM stages from free-text imaging and histopathology reportsAndres Tamm, Helen J S Jones, Neel Doshi, et al.Pageof 57